MEDICO · Medico Remedies Limited · Financials
Market Cap
1.53B INR
Shares
82.98M
Volume · Nov 13
218.52K
Avg daily vol (3M)
425.19K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
2.06B
+36.7%
FY2026
Net Income
131.15M
+29.9%
FY2026
Operating Cash Flow
58.74M
+20.1%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|---|
| INR | 2.59B | 2.06B | 1.51B | 1.45B | 1.4B |
| INR | 30.68M | 30.95M | 30.3M | 28.79M | 27.21M |
| INR | 21.45M | 18.06M | 11.59M | 8.24M | 7.47M |
| INR | 187.62M | 180.6M | 135.04M | 113.35M | 100.99M |
| INR | 51.36M | 49.44M | 34.11M | 30.44M | 28.57M |
| INR | 136.26M | 131.15M | 100.93M | 82.91M | 72.42M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.